Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

47.22
+0.46000.98%
Pre-market: 47.780.5600+1.19%08:20 EST
Volume:4.15M
Turnover:196.81M
Market Cap:114.04B
PE:12.56
High:47.74
Open:47.10
Low:47.10
Close:46.76
52wk High:60.12
52wk Low:44.62
Shares:2.42B
Float Shares:2.20B
Volume Ratio:0.80
T/O Rate:0.19%
Dividend:2.27
Dividend Rate:4.81%
EPS(TTM):3.76
EPS(LYR):3.76
ROE:6.66%
ROA:4.65%
PB:1.36
PE(LYR):12.56

Loading ...

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
20 hours ago

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
21 hours ago

Sector Update: Health Care

MT Newswires Live
·
Feb 20

Sanofi Sued by Texas Attorney General Over Alleged Provider 'Bribery'

MT Newswires Live
·
Feb 20

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ocular Therapeutix (OCUL) and Sanofi (SNY)

TIPRANKS
·
Feb 20

Press Release: Sanofi announces leadership evolution in Specialty Care Business Unit

Dow Jones
·
Feb 17

Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients

Benzinga_recent_news
·
Feb 17

Teva and Sanofi’s duvakitug Phase 2b data shows efficacy in colitis and Crohn’s

TIPRANKS
·
Feb 17

Looking for Dividends? Consider Europe. -- Barrons.com

Dow Jones
·
Feb 16

Income Investing: Looking for Dividends? Consider Europe. -- Barron's

Dow Jones
·
Feb 14

Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors

Benzinga
·
Feb 13

Sanofi's CEO Change Adds to Near-Term Uncertainty -- Market Talk

Dow Jones
·
Feb 13

Sanofi's New CEO Confronts Dual Hurdles: Sluggish R&D and Trump Era Uncertainties

Stock News
·
Feb 13

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Feb 13

Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'

Benzinga
·
Feb 12

Sanofi ‘decides not to renew’ mandate of CEO Paul Hudson

TIPRANKS
·
Feb 12

Sanofi says Belen Garijo to succeed Paul Hudson as CEO

TIPRANKS
·
Feb 12

Sanofi Abruptly Replaces CEO Amid R&D Setbacks, Merck Executive Takes Helm

Stock News
·
Feb 12

Sanofi Names Merck KGaA's Belen Garijo to Replace Paul Hudson as CEO -- Update

Dow Jones
·
Feb 12

Looking for Dividends? Consider Europe. -- Barrons.com

Dow Jones
·
Feb 12